Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 98

1.

Screening with whole-body magnetic resonance imaging in pediatric subjects with Li-Fraumeni syndrome: A single institution pilot study.

O'Neill AF, Voss SD, Jagannathan JP, Kamihara J, Nibecker C, Itriago-Araujo E, Masciari S, Parker E, Barreto M, London WB, Garber JE, Diller L.

Pediatr Blood Cancer. 2018 Feb;65(2). doi: 10.1002/pbc.26822. Epub 2017 Oct 27.

PMID:
29077256
2.

Revisiting tumor patterns and penetrance in germline TP53 mutation carriers: temporal phases of Li-Fraumeni syndrome.

Amadou A, Waddington Achatz MI, Hainaut P.

Curr Opin Oncol. 2018 Jan;30(1):23-29. doi: 10.1097/CCO.0000000000000423. Review.

PMID:
29076966
3.

Identification and Management of TP53 Gene Carriers Detected Through Multigene Panel Testing.

Pal T, Brzosowicz J, Valladares A, Wiesner GL, Laronga C.

South Med J. 2017 Oct;110(10):643-648. doi: 10.14423/SMJ.0000000000000711.

PMID:
28973705
4.

Whole-exome analysis of a Li-Fraumeni family trio with a novel TP53 PRD mutation and anticipation profile.

Franceschi S, Spugnesi L, Aretini P, Lessi F, Scarpitta R, Galli A, Congregati C, Caligo MA, Mazzanti CM.

Carcinogenesis. 2017 Sep 1;38(9):938-943. doi: 10.1093/carcin/bgx069.

PMID:
28911001
5.

Higher-than-expected population prevalence of potentially pathogenic germline TP53 variants in individuals unselected for cancer history.

de Andrade KC, Mirabello L, Stewart DR, Karlins E, Koster R, Wang M, Gapstur SM, Gaudet MM, Freedman ND, Landi MT, Lemonnier N, Hainaut P, Savage SA, Achatz MI.

Hum Mutat. 2017 Dec;38(12):1723-1730. doi: 10.1002/humu.23320. Epub 2017 Sep 21.

PMID:
28861920
6.

Successful Treatment of Recurrent Li-Fraumeni Syndrome-related Choroid Plexus Carcinoma.

McEvoy M, Robison N, Manley P, Yock T, Konopka K, Brown RE, Wolff J, Green AL.

J Pediatr Hematol Oncol. 2017 Nov;39(8):e473-e475. doi: 10.1097/MPH.0000000000000965.

PMID:
28859040
7.

Li-Fraumeni Syndrome Disease Model: A Platform to Develop Precision Cancer Therapy Targeting Oncogenic p53.

Zhou R, Xu A, Gingold J, Strong LC, Zhao R, Lee DF.

Trends Pharmacol Sci. 2017 Oct;38(10):908-927. doi: 10.1016/j.tips.2017.07.004. Epub 2017 Aug 14. Review.

PMID:
28818333
8.

Osteosarcoma: Molecular Pathogenesis and iPSC Modeling.

Lin YH, Jewell BE, Gingold J, Lu L, Zhao R, Wang LL, Lee DF.

Trends Mol Med. 2017 Aug;23(8):737-755. doi: 10.1016/j.molmed.2017.06.004. Epub 2017 Jul 20. Review.

PMID:
28735817
9.

Cancer Screening Recommendations for Individuals with Li-Fraumeni Syndrome.

Kratz CP, Achatz MI, Brugières L, Frebourg T, Garber JE, Greer MC, Hansford JR, Janeway KA, Kohlmann WK, McGee R, Mullighan CG, Onel K, Pajtler KW, Pfister SM, Savage SA, Schiffman JD, Schneider KA, Strong LC, Evans DGR, Wasserman JD, Villani A, Malkin D.

Clin Cancer Res. 2017 Jun 1;23(11):e38-e45. doi: 10.1158/1078-0432.CCR-17-0408. Review.

10.

Recommendations for Surveillance for Children with Leukemia-Predisposing Conditions.

Porter CC, Druley TE, Erez A, Kuiper RP, Onel K, Schiffman JD, Wolfe Schneider K, Scollon SR, Scott HS, Strong LC, Walsh MF, Nichols KE.

Clin Cancer Res. 2017 Jun 1;23(11):e14-e22. doi: 10.1158/1078-0432.CCR-17-0428. Review.

11.

Germline TP53 mutations result into a constitutive defect of p53 DNA binding and transcriptional response to DNA damage.

Zerdoumi Y, Lanos R, Raad S, Flaman JM, Bougeard G, Frebourg T, Tournier I.

Hum Mol Genet. 2017 Jul 15;26(14):2591-2602. doi: 10.1093/hmg/ddx106. Erratum in: Hum Mol Genet. 2017 Jul 15;26(14 ):2812.

12.

Should Genetic Testing be Offered for Children? The Perspectives of Adolescents and Emerging Adults in Families with Li-Fraumeni Syndrome.

Alderfer MA, Lindell RB, Viadro CI, Zelley K, Valdez J, Mandrell B, Ford CA, Nichols KE.

J Genet Couns. 2017 Oct;26(5):1106-1115. doi: 10.1007/s10897-017-0091-x. Epub 2017 Mar 16.

PMID:
28303452
13.

The psychosocial effects of the Li-Fraumeni Education and Early Detection (LEAD) program on individuals with Li-Fraumeni syndrome.

Ross J, Bojadzieva J, Peterson S, Noblin SJ, Yzquierdo R, Askins M, Strong L.

Genet Med. 2017 Sep;19(9):1064-1070. doi: 10.1038/gim.2017.8. Epub 2017 Mar 16.

14.

Allele-specific wild-type TP53 expression in the unaffected carrier parent of children with Li-Fraumeni syndrome.

Buzby JS, Williams SA, Schaffer L, Head SR, Nugent DJ.

Cancer Genet. 2017 Feb;211:9-17. doi: 10.1016/j.cancergen.2017.01.001. Epub 2017 Jan 9.

15.

Inherited TP53 Mutations and the Li-Fraumeni Syndrome.

Guha T, Malkin D.

Cold Spring Harb Perspect Med. 2017 Apr 3;7(4). pii: a026187. doi: 10.1101/cshperspect.a026187. Review.

PMID:
28270529
16.

Familial Melanoma Associated with Li-Fraumeni Syndrome and Atypical Mole Syndrome: Total-body Digital Photography, Dermoscopy and Confocal Microscopy.

Giavedoni P, Ririe M, Carrera C, Puig S, Malvehy J.

Acta Derm Venereol. 2017 Jun 9;97(6):720-723. doi: 10.2340/00015555-2639.

17.

Association of Li-Fraumeni Syndrome With Small Cell Carcinoma of the Ovary, Hypercalcemic Type and Concurrent Pleomorphic Liposarcoma of the Cervix.

Tandon B, Hagemann IS, Maluf HM, Pfeifer JD, Al-Kateb H.

Int J Gynecol Pathol. 2017 Nov;36(6):593-599. doi: 10.1097/PGP.0000000000000365.

PMID:
28177947
18.

Pleomorphic myxoid liposarcoma in an adolescent with Li-Fraumeni syndrome.

Sinclair TJ, Thorson CM, Alvarez E, Tan S, Spunt SL, Chao SD.

Pediatr Surg Int. 2017 May;33(5):631-635. doi: 10.1007/s00383-017-4063-x. Epub 2017 Feb 3.

PMID:
28160093
19.

The Features of Colorectal Tumors in a Patient with Li-Fraumeni Syndrome.

Yoshida T, Tajika M, Tanaka T, Ishihara M, Hirayama Y, Mizuno N, Hara K, Hijioka S, Imaoka H, Hieda N, Okuno N, Kinoshita T, Bhatia V, Shimizu Y, Yatabe Y, Yamao K, Niwa Y.

Intern Med. 2017;56(3):295-300. doi: 10.2169/internalmedicine.56.7274. Epub 2017 Feb 1.

20.

Estimating TP53 Mutation Carrier Probability in Families with Li-Fraumeni Syndrome Using LFSPRO.

Peng G, Bojadzieva J, Ballinger ML, Li J, Blackford AL, Mai PL, Savage SA, Thomas DM, Strong LC, Wang W.

Cancer Epidemiol Biomarkers Prev. 2017 Jun;26(6):837-844. doi: 10.1158/1055-9965.EPI-16-0695. Epub 2017 Jan 30.

Supplemental Content

Loading ...
Support Center